Home > CDMO Services > Custom Synthesis & Lyophilization
Custom Synthesis & Lyophilization
Abiozen offers specialized capabilities in Custom Synthesis and Lyophilization to support the development of high-complexity, high-value pharmaceutical products. These services are designed for clients requiring precise molecular engineering and stability enhancement, especially for high-potency APIs and sensitive biologics. Executed under stringent GMP conditions, our solutions ensure product integrity, purity, and sterility from early development through to commercial supply.
Custom Synthesis for Complex Molecules
We specialize in synthesizing structurally intricate and high-potency compounds, including chiral APIs, peptides, and other challenging chemistries. Our scientists utilize advanced methodologies such as flow chemistry and microwave-assisted synthesis to enhance reaction efficiency, reproducibility, and scalability. Each synthesis route is developed with a focus on purity, yield, and regulatory alignment, ensuring readiness for both clinical and commercial applications.
High-Purity, Scalable API Development
Whether producing milligram-scale quantities for early-stage R&D or multi-kilogram batches for commercial production, our synthesis capabilities are highly adaptable. We manage the entire lifecycle from route design and impurity profiling to final crystallization and isolation, delivering APIs that meet stringent quality specifications and global regulatory expectations.
Advanced Lyophilization Capabilities
Our lyophilization (freeze-drying) services provide a critical solution for formulating temperature-sensitive APIs and biologics. Equipped with automated loading systems and programmable freeze-dryers, our facilities support consistent sublimation cycles that minimize residual moisture while preserving molecular structure. This extends shelf life, enhances transport stability, and maintains sterility across a wide range of injectable dosage forms.
Sterile and Contamination-Controlled Environments
All synthesis and lyophilization operations are conducted in classified cleanroom environments, with comprehensive contamination control protocols. We ensure compliance with international sterility and environmental standards, making our solutions ideal for parenteral products, oncology APIs, and other critical-use compounds.
Integrated Support for Clinical and Commercial Supply
Our team works closely with clients to align custom synthesis and lyophilization workflows with downstream development, tech transfer, and regulatory submission strategies. With a strong emphasis on quality, scalability, and risk mitigation, Abiozen helps pharmaceutical innovators bring complex, high-stability products to market faster and more confidently.
Connect with Abiozen
We thrive on tackling complex challenges—and we’d love to learn about yours. Reach out to explore how we can support your program’s unique requirements.
Related Resources

Accelerated Market Access with CRDMO-Style Development & Manufacturing
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Integrated API to Commercial Manufacturing: The Patheon Parallel
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Curia-Level Excellence in End-to-End Drug Development Solutions
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Accelerated Market Access with CRDMO-Style Development & Manufacturing
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Integrated API to Commercial Manufacturing: The Patheon Parallel
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste

Accelerated Market Access with CRDMO-Style Development & Manufacturing
property and compliance solutions for seamless market entry processes for superior purity and stability. global demand. absence of microbial contamination, essential for injectable products compliance with ICH Q3C guidelines, ensuring safety and purity residual moisture levels below 1%, critical for long-term stability. for HPAPIs, equipped with decontamination protocols and waste